IMRFX
Price
$13.07
Change
+$0.50 (+3.98%)
Updated
Apr 9 closing price
Net Assets
281.09M
RIRAX
Price
$68.90
Change
+$2.55 (+3.84%)
Updated
Apr 9 closing price
Net Assets
100.5B
Ad is loading...

IMRFX vs RIRAX

Header iconIMRFX vs RIRAX Comparison
Open Charts IMRFX vs RIRAXBanner chart's image
Columbia Global Opportunities A
Price$13.07
Change+$0.50 (+3.98%)
VolumeN/A
Net Assets281.09M
American Funds Capital Income Bldr R1
Price$68.90
Change+$2.55 (+3.84%)
VolumeN/A
Net Assets100.5B
IMRFX vs RIRAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IMRFX vs. RIRAX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMRFX is a Hold and RIRAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RIRAX has more cash in the bank: 100B vs. IMRFX (281M). RIRAX pays higher dividends than IMRFX: RIRAX (2.40) vs IMRFX (0.47). IMRFX was incepted earlier than RIRAX: IMRFX (40 years) vs RIRAX (23 years). RIRAX (1.36) is less costly to investors than IMRFX (1.22). RIRAX has a lower initial minimum investment than IMRFX: RIRAX (250) vs IMRFX (2000). RIRAX annual gain was more profitable for investors over the last year : 0.24 vs. IMRFX (-2.72). RIRAX return over 5 years is better than : 31.80 vs. IMRFX (-1.68).
IMRFXRIRAXIMRFX / RIRAX
Total Expense Ratio1.221.3690%
Annual Report Gross Expense Ratio1.221.3690%
Fund Existence40 years23 years-
Gain YTD-6.889-3.546194%
Front Load6%N/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets281M100B0%
Annual Yield % from dividends0.472.4020%
Returns for 1 year-2.720.24-1,129%
Returns for 3 years-9.162.49-368%
Returns for 5 years-1.6831.80-5%
Returns for 10 years11.3722.1651%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRS34.262.83
+9.00%
Leonardo DRS
HNI43.242.98
+7.40%
HNI Corp
ZIMV9.560.43
+4.71%
ZimVie
RNAZ0.38-0.01
-2.45%
TransCode Therapeutics Inc
FTEL0.64-0.03
-4.38%
Fitell Corp